Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Laid off workers can now get a free month of ketamine assisted therapy services to help with their mental health

The free service from Field Trip Health is open to "anyone who's facing headwinds right now."

Fortune

3 Stocks That Still Have Room to Run

With the October inflation report showing signs of cooling and anticipations of a slowdown in interest rate hikes, the stock market looks poised to extend its recent rally. Hence, it could be wise to invest in fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and Raytheon Technologies (RTX) that still…

StockNews.com

New Alzheimer's drug faces uncertain regulatory path

The FDA will soon decide whether to approve Eisai's experimental drug lecanemab.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

WEKU

Drug slows Alzheimer's but can it make a real difference?

New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening

The Independent UK

Vet's lawsuit blaming antimalarial drug for psychosis tossed

A lawsuit against the maker of an anti-malarial drug blamed for causing psychotic and neurological damage in U.S. servicemembers has been thrown out

The Independent UK

Safety concerns hang over new Alzheimer's treatment

Two deaths linked to the drug may present a more complicated path to approval.

Axios

Read news from The Economist, FT, and more,
with one subscription

The chase is on: Regulators are slowly cracking down on vapes aimed at teens

The advent of vaping revived nicotine addiction among young people after a dramatic decline. The FDA seems poised to at last yank some products aimed at teens from the market. Will it work?

WEKU

1 High-Dividend Stock to Add to Your Portfolio if You Haven’t Already

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

StockNews.com

NVI plans to utilise local booster shots

The National Vaccine Institute (NVI) plans to use locally developed Covid-19 vaccines as booster shots when they are completed and approved by the Food and Drug Administration (FDA).

Bangkok Post

3 Strong Buy Stocks to Continue to Hold Onto in 2023

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

StockNews.com

Come Next Thanksgiving, We Might Be Giving Thanks for Government-Approved, Lab-Grown Turkey

Regulators are beginning to smile on the sci-fi project of creating real meat products without the typical death and environmental destruction.

Reason

Psychedelic mushrooms expand Jamaica tourism beyond sunshine and reggae

A new group of Jamaican resorts is promoting tourism that offers mystical experiences and stress relief through "magic mushrooms," as the Caribbean nation seeks to develop a niche industry in natural psychedelics.

Reuters

Gene therapy at $3.5m a dose approved for US adults with hemophilia B

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

The Independent UK

$3.5M gene therapy for hemophilia gets FDA approval

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

The Guardian - UK

‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s?

After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough

Tribune News Service

Era of hope for patients with lung cancer

November is Lung Cancer Awareness month. Lung cancer is the most common cancer worldwide, with more than 2.1 million cases, according to the American Lung Association.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Anti-abortion group that helped overturn Roe v Wade sues FDA to revoke approval of abortion drug

Conservative Christian group takes aim at abortion drug that is also used to treat miscarriages

Tribune News Service

Lawsuit seeks to reverse FDA approval of abortion-inducing pill mifepristone

AUSTIN, Texas — Abortion opponents on Friday asked a federal court to yank federal approval of a pill used to end pregnancies.

The Guardian - UK

First Thing: Elon Musk shuts Twitter offices to staff after wave of resignations

The social media firm is struggling to retain workers after Musk demanded they sign a pledge committing to being ‘extremely hardcore’. Plus, lab-grown meat officially safe to eat in the US

Los Angeles Times

Michael Hiltzik: The right wing gets its knives out for California's new medical misinformation law

Painfully aware of how attacks on COVID vaccines and anti-pandemic policies have undermined public health, California enacted a law this year that makes spreading medical misinformation and disinformation about the pandemic grounds for revoking a doctor's license.

The Guardian - US

US declares lab-grown meat safe to eat in ‘groundbreaking’ move

The government’s approval will open the market for a food praised for being more efficient and environmentally friendly

Reason

12 Republicans Support Same-Sex Marriage in Key Senate Vote

Plus: What Orion is carrying to the moon, when you might be able to munch on some lab-grown meat, and more...

Bangkok Post

FDA: Nasal spray product 'not anti-Covid'

The Food and Drug Administration (FDA) says it would take legal action against advertisements that mislead the public into believing that a nasal spray product can prevent or treat Covid-19.

1 … 171 172 173 174

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.